342 related articles for article (PubMed ID: 24345269)
21. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.
Grayson B; Idris NF; Neill JC
Behav Brain Res; 2007 Nov; 184(1):31-8. PubMed ID: 17675172
[TBL] [Abstract][Full Text] [Related]
22. Serotonin receptors as targets for drugs useful to treat psychosis and cognitive impairment in schizophrenia.
Meltzer HY; Massey BW; Horiguchi M
Curr Pharm Biotechnol; 2012 Jun; 13(8):1572-86. PubMed ID: 22283753
[TBL] [Abstract][Full Text] [Related]
23. 5-HT
Huang M; Kwon S; Rajagopal L; He W; Meltzer HY
Psychopharmacology (Berl); 2018 Oct; 235(10):2795-2808. PubMed ID: 30066135
[TBL] [Abstract][Full Text] [Related]
24. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats.
Potasiewicz A; Hołuj M; Kos T; Popik P; Arias HR; Nikiforuk A
Neuropharmacology; 2017 Feb; 113(Pt A):188-197. PubMed ID: 27717880
[TBL] [Abstract][Full Text] [Related]
25. MK-801-induced deficits in social recognition in rats: reversal by aripiprazole, but not olanzapine, risperidone, or cannabidiol.
Deiana S; Watanabe A; Yamasaki Y; Amada N; Kikuchi T; Stott C; Riedel G
Behav Pharmacol; 2015 Dec; 26(8 Spec No):748-65. PubMed ID: 26287433
[TBL] [Abstract][Full Text] [Related]
26. Attenuation of phencyclidine-induced object recognition deficits by the combination of atypical antipsychotic drugs and pimavanserin (ACP 103), a 5-hydroxytryptamine(2A) receptor inverse agonist.
Snigdha S; Horiguchi M; Huang M; Li Z; Shahid M; Neill JC; Meltzer HY
J Pharmacol Exp Ther; 2010 Feb; 332(2):622-31. PubMed ID: 19864614
[TBL] [Abstract][Full Text] [Related]
27. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
Karasawa J; Hashimoto K; Chaki S
Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
[TBL] [Abstract][Full Text] [Related]
28. Serotonin (5-HT)1A receptor agonism and 5-HT7 receptor antagonism ameliorate the subchronic phencyclidine-induced deficit in executive functioning in mice.
Rajagopal L; Massey BW; Michael E; Meltzer HY
Psychopharmacology (Berl); 2016 Feb; 233(4):649-60. PubMed ID: 26558619
[TBL] [Abstract][Full Text] [Related]
29. Anabasine, a selective nicotinic acetylcholine receptor agonist, antagonizes MK-801-elicited mouse popping behavior, an animal model of schizophrenia.
Mastropaolo J; Rosse RB; Deutsch SI
Behav Brain Res; 2004 Aug; 153(2):419-22. PubMed ID: 15265637
[TBL] [Abstract][Full Text] [Related]
30. Serotonin receptors: their key role in drugs to treat schizophrenia.
Meltzer HY; Li Z; Kaneda Y; Ichikawa J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
[TBL] [Abstract][Full Text] [Related]
31. GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.
Rajagopal L; Burgdorf JS; Moskal JR; Meltzer HY
Behav Brain Res; 2016 Feb; 299():105-10. PubMed ID: 26632337
[TBL] [Abstract][Full Text] [Related]
32. A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists.
Buccafusco JJ; Terry AV
Biochem Pharmacol; 2009 Oct; 78(7):852-62. PubMed ID: 19577545
[TBL] [Abstract][Full Text] [Related]
33. Neurochemical arguments for the use of dopamine D
Huang M; Kwon S; He W; Meltzer HY
Pharmacol Biochem Behav; 2017 Jun; 157():16-23. PubMed ID: 28455126
[TBL] [Abstract][Full Text] [Related]
34. The dopamine D₃-preferring D₂/D₃ dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia.
Watson DJG; King MV; Gyertyán I; Kiss B; Adham N; Fone KCF
Eur Neuropsychopharmacol; 2016 Feb; 26(2):208-224. PubMed ID: 26723167
[TBL] [Abstract][Full Text] [Related]
35. Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists.
Radek RJ; Kohlhaas KL; Rueter LE; Mohler EG
Curr Pharm Des; 2010 Jan; 16(3):309-22. PubMed ID: 20109141
[TBL] [Abstract][Full Text] [Related]
36. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY
J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459
[TBL] [Abstract][Full Text] [Related]
37. Muscarinic receptor signaling contributes to atypical antipsychotic drug reversal of the phencyclidine-induced deficit in novel object recognition in rats.
Miyauchi M; Neugebauer NM; Sato T; Ardehali H; Meltzer HY
J Psychopharmacol; 2017 Dec; 31(12):1588-1604. PubMed ID: 28946779
[TBL] [Abstract][Full Text] [Related]
38. PCP-induced deficits in murine nest building activity: employment of an ethological rodent behavior to mimic negative-like symptoms of schizophrenia.
Pedersen CS; Sørensen DB; Parachikova AI; Plath N
Behav Brain Res; 2014 Oct; 273():63-72. PubMed ID: 25064467
[TBL] [Abstract][Full Text] [Related]
39. The novel antipsychotic drug lurasidone enhances N-methyl-D-aspartate receptor-mediated synaptic responses.
Yuen EY; Li X; Wei J; Horiguchi M; Meltzer HY; Yan Z
Mol Pharmacol; 2012 Feb; 81(2):113-9. PubMed ID: 22072817
[TBL] [Abstract][Full Text] [Related]
40. Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors.
Nagai T; Murai R; Matsui K; Kamei H; Noda Y; Furukawa H; Nabeshima T
Psychopharmacology (Berl); 2009 Jan; 202(1-3):315-28. PubMed ID: 18679658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
